JPS494391A - - Google Patents

Info

Publication number
JPS494391A
JPS494391A JP47043475A JP4347572A JPS494391A JP S494391 A JPS494391 A JP S494391A JP 47043475 A JP47043475 A JP 47043475A JP 4347572 A JP4347572 A JP 4347572A JP S494391 A JPS494391 A JP S494391A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP47043475A
Other languages
Japanese (ja)
Other versions
JPS5020395B2 (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP47043475A priority Critical patent/JPS5020395B2/ja
Publication of JPS494391A publication Critical patent/JPS494391A/ja
Publication of JPS5020395B2 publication Critical patent/JPS5020395B2/ja
Expired legal-status Critical Current

Links

JP47043475A 1972-04-30 1972-04-30 Expired JPS5020395B2 (en:Method)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP47043475A JPS5020395B2 (en:Method) 1972-04-30 1972-04-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47043475A JPS5020395B2 (en:Method) 1972-04-30 1972-04-30

Publications (2)

Publication Number Publication Date
JPS494391A true JPS494391A (en:Method) 1974-01-16
JPS5020395B2 JPS5020395B2 (en:Method) 1975-07-15

Family

ID=12664732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47043475A Expired JPS5020395B2 (en:Method) 1972-04-30 1972-04-30

Country Status (1)

Country Link
JP (1) JPS5020395B2 (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282643A3 (en) * 1986-11-22 1990-08-22 The Green Cross Corporation Use of pharmaceutical compositions comprising cyclohexane derivatives in the treatment or prevention of peptic ulcers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282643A3 (en) * 1986-11-22 1990-08-22 The Green Cross Corporation Use of pharmaceutical compositions comprising cyclohexane derivatives in the treatment or prevention of peptic ulcers

Also Published As

Publication number Publication date
JPS5020395B2 (en:Method) 1975-07-15

Similar Documents

Publication Publication Date Title
JPS5133727Y2 (en:Method)
AU465382B2 (en:Method)
JPS5031506B2 (en:Method)
JPS5242231B2 (en:Method)
AU4040772A (en:Method)
BG18764A1 (en:Method)
AU479996A (en:Method)
BG18088A1 (en:Method)
BG18143A1 (en:Method)
BG18206A1 (en:Method)
BG18288A1 (en:Method)
BG18311A1 (en:Method)
BG18359A1 (en:Method)
BG18388A1 (en:Method)
BG18439A1 (en:Method)
BG18684A1 (en:Method)
BG18685A1 (en:Method)
BG18780A1 (en:Method)
BG19066A1 (en:Method)
BG19300A1 (en:Method)
BG20493A1 (en:Method)
BG20736A1 (en:Method)
BG20750A3 (en:Method)
BG21622A1 (en:Method)
BG26664A4 (en:Method)